Aveanna Healthcare Holdings Inc

Análisis de la acción Aveanna Healthcare Holdings Inc (AVAH)

$12.360

+0.183 (+1.48%)Al cierre

Loading chart…
Máximo
12.380
Apertura
12.070
Precio medio ponderado por volumen
12.27
Volumen
2.03M
Capitalización
492.49M
Mínimo
12.070
Importe
24.89M
EV/EBITDA, TTM
10.32

Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. The Company's segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. The HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. The Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The MS business serves patients who have short or long-term disabilities and require a supply of infant, pediatric and adult formulas.

ir.aveanna.com

Análisis de IA of Aveanna Healthcare Holdings Inc (AVAH)

Mantener

Aveanna Healthcare is currently a hold. The stock has a current price of $12.25, which is below the analyst price target of $15, suggesting potential upside. However, the RSI is at 32.085, indicating that the stock is oversold, which could mean a price rebound is possible. The recent insider selling has increased by 675.38%, which raises concerns about the stock's immediate outlook. Therefore, while there is potential for long-term gains, the current market sentiment and technical indicators suggest caution.

Métricas de valoración

El PER previsto actual de Aveanna Healthcare Holdings Inc (AVAH) es 13.32, frente a su media de 5 años de 37.40.

PER previsto

Valor razonable
Media 5A P/E
37.40
P/E actual
13.32
Sobrevalorada
140.10
Infravalorada
-65.29

EV/EBITDA previsto

Infravalorado
Media 5A EV/EBITDA
11.87
EV/EBITDA actual
10.32
Sobrevalorada
13.41
Infravalorada
10.32

Precio/ventas previsto

Muy sobrevalorado
Media 5A P/S
0.41
P/S actual
0.92
Sobrevalorada
0.65
Infravalorada
0.17

Escenarios de precio de Alphio AI para AVAH

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%AVAH

$6.77

Precio del escenario

B

Base

Base · 50%AVAH

$6.66

Precio del escenario

B

Bajista

Bajista · 25%AVAH

$6.42

Precio del escenario

Ballenas con AVAH en cartera

B

Braidwell LP

+ Con en carteraAVAH

+13.80%

Rentabilidad a 3 meses

J

Jaunty Global Limited

+ Con en carteraAVAH

+0.65%

Rentabilidad a 3 meses

Cronología de eventos

2026-08-20 (ET)

21:00:00

RBC Capital Prices Deal Within $11.65-$11.90 Range

20:00:00

US Treasury Yields Rise, Dow Drops Over 700 Points

16:30:00

Aveanna Healthcare Launches Secondary Offering of 15 Million Shares

2026-08-13 (ET)

07:30:00

Aveanna Reports Q2 Revenue of $670.48M, Exceeds Expectations

07:30:00

Aveanna Raises FY26 Adjusted EBITDA Outlook to Over $365M

Noticias

Preguntas frecuentes sobre AVAH, respondidas por Alphio AI

Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. The Company's segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. The HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. The Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The MS business serves patients who have short or long-term disabilities and require a supply of infant, pediatric and adult formulas. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).

Aveanna Healthcare is currently a hold. The stock has a current price of $12.25, which is below the analyst price target of $15, suggesting potential upside. However, the RSI is at 32.085, indicating that the stock is oversold, which could mean a price rebound is possible. The recent insider selling has increased by 675.38%, which raises concerns about the stock's immediate outlook. Therefore, while there is potential for long-term gains, the current market sentiment and technical indicators suggest caution.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar